Jump to Main Content
- Esteban-Lopez, Maria, et al. Show all 3 Authors
- Molecular and cellular endocrinology 2019 v.487 pp. 40-44
- G-protein coupled receptors; agonists; cardiovascular diseases; drugs; half life; intravenous injection; ligands; liver cirrhosis; muscles; peptide receptors; relaxin; therapeutics
- ... The peptide hormone relaxin has beneficial roles in several organs through its action on its cognate G protein-coupled receptor, RXFP1. Relaxin administration is limited to intravenous, subcutaneous, intramuscular, or spinal injection. Another drawback of peptide-based therapy is the short half-life, which requires continuous delivery of the drug to achieve efficient concentration in target organs ...